IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $792,000 | -65.9% | 25,000 | -50.0% | 0.01% | -60.0% |
| Q4 2020 | $2,320,000 | -68.0% | 50,000 | -77.3% | 0.02% | -81.9% |
| Q3 2020 | $7,242,000 | +427.5% | 219,982 | +340.0% | 0.14% | +273.0% |
| Q2 2020 | $1,373,000 | +83.6% | 50,000 | +100.0% | 0.04% | +19.4% |
| Q1 2020 | $748,000 | -80.1% | 25,000 | -81.6% | 0.03% | -74.8% |
| Q4 2019 | $3,766,000 | +67.4% | 136,040 | +10.1% | 0.12% | +36.7% |
| Q3 2019 | $2,250,000 | +22.3% | 123,599 | +64.8% | 0.09% | +109.3% |
| Q2 2019 | $1,839,000 | +28.9% | 75,000 | -50.0% | 0.04% | -2.3% |
| Q1 2019 | $1,427,000 | +7.5% | 150,000 | 0.0% | 0.04% | -17.0% |
| Q4 2018 | $1,328,000 | -5.5% | 150,000 | +20.0% | 0.05% | +76.7% |
| Q3 2018 | $1,406,000 | +119.7% | 125,000 | +150.0% | 0.03% | +87.5% |
| Q2 2018 | $640,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |